Ron Finklestien

Altimmune’s Stock Surge and the Pemvidutide Breakthrough Altimmune’s Stock Surge and the Pemvidutide Breakthrough

Altimmune, Inc. ALT shares are trading higher Thursday, and the stock has gained more than 140% over the past month. Here's a look at what's going on. ...

Analysts Predict U.S. Banking Stocks Rally in 2024 Amid Economic Shifts ...

A potential soft landing for the U.S. economy has sparked an upswing of interest in U.S. banking stocks, elucidated in a recent note to clients by Bank of America on Thursday.The group of Bank...

Is Lamb Weston’s (LW) Stock a Buy After Solid Quarterly Results? Is Lamb Weston’s (LW) Stock a Buy After Solid Quarterly Results?

After revealing strong fiscal second-quarter results on Thursday, investors might be contemplating whether it's the opportune moment to grab a slice of Lamb Weston’s stock. The company, in recent years, has garnered considerable attention on Wall Street, analogous...

GigaCloud Surpasses 52-Week Highs: The Tech Surge GigaCloud Surpasses...

GigaCloud Technology Inc GCT shares rose significantly on Thursday, marking an exceptional period of growth over the...

Voyager Therapeutics Announces Proposed Public Offering Voyager Therapeutics Shares Plummet After-Hours Due to $100 Million Public Offering

Voyager Therapeutics Proposes Public Offering Voyager Therapeutics, Inc. VYGR witnessed a significant decline in after-hours trading following the announcement of a proposed public offering of $100 million. This move comes as Voyager Therapeutics initiates an underwritten public offering to raise...